The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror?
- DOI
- 10.1080/14796694.2026.2725499
- Published
- 2026-08-28
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2725499,
title = {The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror?},
author = {Wolfram C. M. Dempke and Christoph Sippel and Klaus Fenchel and Volker Heinemann and Eric van Cutsem and Dirk Arnold},
year = {2026},
journal = {Future Oncology},
doi = {10.1080/14796694.2026.2725499},
url = {https://doi.org/10.1080/14796694.2026.2725499}
}RIS
TY - JOUR TI - The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror? AU - Wolfram C. M. Dempke AU - Christoph Sippel AU - Klaus Fenchel AU - Volker Heinemann AU - Eric van Cutsem AU - Dirk Arnold PY - 2026 JO - Future Oncology DO - 10.1080/14796694.2026.2725499 UR - https://doi.org/10.1080/14796694.2026.2725499 ER -
APA
Dempke, W. C. M., Sippel, C., Fenchel, K., Heinemann, V., Cutsem, E. V., & Arnold, D. (2026). The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror?. Future Oncology. https://doi.org/10.1080/14796694.2026.2725499
Source records
- crossref · retrieved 2026-09-26T03:57:53.756Z